Number To Know…14
The FDA cited 14 different good manufacturing practice and good tissue practice violations made by the US Stem Cell Clinic in a recent warning letter. The slap on the wrist is part of the agency's crackdown on dishonest practitioners of regenerative medicine.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.